National Patient Group Direction Templates and Medicines Policy & Governance Principles
Released in 2016 the first Carter report set the scene for improving both efficiency and productivity across NHS acute hospitals; in May 2018 the second Carter report was published. This second report makes a recommendation (Recommendation 11) to improve both efficiency and productivity in the NHS by standardising the development and distribution of PGDs, medicines policies and other essential organisational governance documents across NHS organisations with the aim of releasing significant local resource to be redeployed on optimising outcomes from medicines use.
SPS has established the Medicines Governance Do Once (MGDO) Programme Board which provides oversight for this ‘Do Once’ project. The outputs are intended for use by NHS commissioned and publicly funded services in England.
What are the benefits to organisations?
- Consistency, quality and reduced variability
- Alignment with national guidance
- Increased organisational capacity releasing local resources to work within other medicines optimisation areas
Patient Group Direction Templates
PGD templates will be developed in Short Life Working Groups (SLWGs) which will include Subject Matter Experts (SMEs) and relevant national clinical bodies. SMEs will be recognised leaders working in the clinical environment where the PGDs will be used. Further details on the process can be found below. The current PGD work plan is also shared. Follow the link below to the published PGD templates.
Implementation guide for national PGD templates – an implementation guide has been produced to support commissioning and provider organisations in the implementation of the national PGD templates within their organisation/commissioned services (see Attachments section below).
PGDs are not always required. We have produced guidance on when PGDs should not be used and advice on alternative mechanisms for supply and administration of medicines. Link
At the request of a number of organisations, we have published the PGD template that we are using when developing the national PGDs. Link
Medicines Policy and Governance Principles
November 2021 – This workstream is currently on hold due to time constraints. There is no timescale of when this workstream will restart.
Medicines policy and governance principles will be developed with the aim of enabling the dissemination of key points for local consideration. Medicines policies, governance principles and associated resources will be developed using existing good practice examples and consensus opinion from Subject Matter Experts (SMEs). SMEs will be recognised leaders working in the clinical environment where the medicines policy or guidance resource will be used. Further details on the process can be found below. The most recent work plan is shared below.